Paper List

Ulka Vaishampayan, Jeremy (M. G.) Taylor, Deepak Kilari, Tanya Dorff, Alexandra Sokolava, Yaxuan Huang, Phillip Palmbos, Jacqueline Brown, Irene Tsung, Megan Caram, Sarah Yentz, Bassel Nazha, Zachery Reichert, Joshi Alumkal

Background: Effective therapies remain a currently unmet need for neuroendocrine prostate cancer (NEPC). Preclinical synergy in small cell cancer, and clinical tolerability led to the conduct of a mul...

Arman Ghavidel, Pilar Pazos, Hyoshin J. Park, John Seems

Prostate cancer risk prediction remains challenged by the inability to reliably distinguish indolent from aggressive disease, leading to overtreatment or undertreatment. Conventional approaches based ...

Sara Damiani, Priscilla Guglielmo, Guya Mansi, Sara Calzolai Lettieri, Giulia Giacoppo, Demetrio Aricò, Lucia Setti, Alessia Artesani, Giovanni Lughezzani, Angelo Porreca, Antonio Selvaggio, Laura Evangelista

Objective. Radiolabelled PSMA PET/CT has demonstrated high diagnostic accuracy in staging patients with intermediate-risk prostate cancer (PCa). However, its role on long-term prognosis and outcome pr...